Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer
- PMID: 21075555
- DOI: 10.1016/j.ijrobp.2010.09.023
Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer
Abstract
Purpose: To demonstrate the feasibility of magnetic resonance lymphography (MRL) -guided delineation of a boost volume and an elective target volume for pelvic lymph node irradiation in patients with prostate cancer. The feasibility of irradiating these volumes with a high-dose boost to the MRL-positive lymph nodes in conjunction with irradiation of the prostate using intensity-modulated radiotherapy (IMRT) was also investigated.
Methods and materials: In 4 prostate cancer patients with a high risk of lymph node involvement but no enlarged lymph nodes on CT and/or MRI, MRL detected pathological lymph nodes in the pelvis. These lymph nodes were identified and delineated on a radiotherapy planning CT to create a boost volume. Based on the location of the MRL-positive lymph nodes, the standard elective pelvic target volume was individualized. An IMRT plan with a simultaneous integrated boost (SIB) was created with dose prescriptions of 42 Gy to the pelvic target volume, a boost to 60 Gy to the MRL-positive lymph nodes, and 72 Gy to the prostate.
Results: All MRL-positive lymph nodes could be identified on the planning CT. This information could be used to delineate a boost volume and to individualize the pelvic target volume for elective irradiation. IMRT planning delivered highly acceptable radiotherapy plans with regard to the prescribed dose levels and the dose to the organs at risk (OARs).
Conclusion: MRL can be used to select patients with limited lymph node involvement for pelvic radiotherapy. MRL-guided delineation of a boost volume and an elective pelvic target volume for selective high-dose lymph node irradiation with IMRT is feasible. Whether this approach will result in improved outcome for these patients needs to be investigated in further clinical studies.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
[Prostate cancer: what treatment techniques for which tumors? Ethical and methodological issues].Cancer Radiother. 2014 Oct;18(5-6):369-78. doi: 10.1016/j.canrad.2014.07.154. Epub 2014 Sep 6. Cancer Radiother. 2014. PMID: 25199865 Review. French.
-
Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?Br J Radiol. 2014 May;87(1037):20130696. doi: 10.1259/bjr.20130696. Epub 2014 Mar 20. Br J Radiol. 2014. PMID: 24646126 Free PMC article.
-
Lymphotropic nanoparticle-enhanced MRI in prostate cancer: value and therapeutic potential.Curr Urol Rep. 2014 Mar;15(3):389. doi: 10.1007/s11934-013-0389-7. Curr Urol Rep. 2014. PMID: 24430170 Review.
-
Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases.Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):712-8. doi: 10.1016/j.ijrobp.2011.12.093. Epub 2012 Mar 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 22417806
-
Ferumoxtran-10 MR lymphography for target definition and follow-up in a patient undergoing image-guided, dose-escalated radiotherapy of lymph nodes upon PSA relapse.Strahlenther Onkol. 2011 Mar;187(3):206-12. doi: 10.1007/s00066-010-2195-1. Epub 2011 Feb 21. Strahlenther Onkol. 2011. PMID: 21347637
Cited by
-
Lymph node imaging in initial staging of prostate cancer: An overview and update.World J Radiol. 2017 Oct 28;9(10):389-399. doi: 10.4329/wjr.v9.i10.389. World J Radiol. 2017. PMID: 29104741 Free PMC article. Review.
-
Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the block.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Jan;10(1):e1471. doi: 10.1002/wnan.1471. Epub 2017 Apr 6. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018. PMID: 28382713 Free PMC article.
-
Application of nanotechnology to cancer radiotherapy.Cancer Nanotechnol. 2016;7(1):11. doi: 10.1186/s12645-016-0024-7. Epub 2016 Dec 19. Cancer Nanotechnol. 2016. PMID: 28066513 Free PMC article. Review.
-
Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning.Semin Radiat Oncol. 2017 Jan;27(1):21-33. doi: 10.1016/j.semradonc.2016.08.008. Epub 2016 Aug 31. Semin Radiat Oncol. 2017. PMID: 27986208 Free PMC article. Review.
-
Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.BMC Urol. 2015 Feb 21;15(1):10. doi: 10.1186/s12894-015-0004-y. BMC Urol. 2015. PMID: 25881245 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical